The measurement of tamoxifen and metabolites in the rat and relationship to the response of DMBA-induced mammary tumours

Add time:08/07/2019    Source:sciencedirect.com

The concentrations of tamoxifen and two of its metabolites, N-desmethyltamoxifen and 4′-hydroxytamoxifen (metabolite B), have been measured in rat plasma and DMBA-induced tumours using gas chromatography-mass spectrometry. At a dose of 100 μg/day all three compounds produced tumour regression and, in the case of tamoxifen, the number and extent of regressions and the inhibition of new tumours were dependent upon dosage. No correlation was observed, however, between tumour regression and the concentrations of tamoxifen or N-desmethyltamoxifen in the plasma of individual animals. When tamoxifen, N-desmethyltamoxifen and metabolite B were measured in oestrogen-receptor-positive tumours a correlation was found between reduction in tumour and the tamoxifen concentration in cytosol fractions. The concentrations of all three compounds in both nuclear and cytosol fractions were higher than could be accounted for by binding to the oestrogen receptor. The mechanistic significance of these high values is, at present, unclear.

We also recommend Trading Suppliers and Manufacturers of N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture) (cas 110025-28-0). Pls Click Website Link as below: cas 110025-28-0 suppliers

Prev:An ultra performance liquid chromatography–tandem MS assay for tamoxifen metabolites profiling in plasma: First evidence of 4′-hydroxylated metabolites in breast cancer patients
Next:Analysis of tamoxifen and 4-hydroxytamoxifen levels in immature rat uterine cytoplasm and KCL-nuclear extracts by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM))